Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)

ClinicalTrials.gov ID: NCT05032859

Public ClinicalTrials.gov record NCT05032859. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 10:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Moderate to Severe Atopic Dermatitis in Children and Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a double-blind, randomized, vehicle controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% compared to vehicle control cream in pediatric and adult subjects with atopic dermatitis.

Study identification

NCT ID
NCT05032859
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Organon and Co
Industry
Enrollment
406 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 23, 2021 (Actual)
Primary completion
Feb 3, 2023 (Actual)
Completion
Feb 8, 2023 (Actual)
Last update posted
Sep 2, 2025

2021 – 2023

United States locations

U.S. sites
57
U.S. states
25
U.S. cities
52
Facility City State ZIP Site status
Dermavant Investigative Site Birmingham Alabama 35244 —
Dermavant Investigative Site Scottsdale Arizona 85255 —
Dermavant Investigative Site Scottsdale Arizona 85260 —
Dermavant Investigative Site Fort Smith Arkansas 72916 —
Dermavant Investigative Site Cerritos California 90702 —
Dermavant Investigative Site Huntington Beach California 92647 —
Dermavant Investigative Site Lancaster California 93534 —
Dermavant Investigative Site Long Beach California 90806 —
Dermavant Investigative Site Los Angeles California 90045 —
Dermavant Investigative Site San Diego California 92123 —
Dermavant Investigative Site San Francisco California 94115 —
Dermavant Investigative Site Santa Ana California 92701 —
Dermavant Investigative Site Santa Monica California 90404 —
Dermavant Investigative Site Boca Raton Florida 33428 —
Dermavant Investigative Site Delray Beach Florida 33484 —
Dermavant Investigative Site Jacksonville Florida 32256 —
Dermavant Investigative Site Miami Florida 33165 —
Dermavant Investigative Site Miami Florida 33173 —
Dermavant Investigative Site Miami Lakes Florida 33014 —
Dermavant Investigative Site Tampa Florida 33607 —
Dermavant Investigative Site Snellville Georgia 30078 —
Dermavant Investigative Site Evansville Indiana 47715 —
Dermavant Investigative Site Overland Park Kansas 66210 —
Dermavant Investigative Site Lexington Kentucky 40517 —
Dermavant Investigative Site Louisville Kentucky 40241 —
Dermavant Investigative Site Baton Rouge Louisiana 70808 —
Dermavant Investigative Site Baton Rouge Louisiana 70809 —
Dermavant Investigative Site New Orleans Louisiana 70115 —
Dermavant Investigative Site Rockville Maryland 20850 —
Dermavant Investigative Site Detroit Michigan 48202 —
Dermavant Investigative Site Lincoln Nebraska 68516 —
Dermavant Investigative Site Omaha Nebraska 68114 —
Dermavant Investigative Site Las Vegas Nevada 89148 —
Dermavant Investigative Site East Windsor New Jersey 08520 —
Dermanvant Investigative Site Brooklyn New York 11203 —
Dermavant Investigative Site Watertown New York 13601 —
Dermavant Investigative Site Charlotte North Carolina 28277 —
Dermavant Investigative Site Dayton Ohio 45414 —
Dermavant Investigative Site Mason Ohio 45040 —
Dermavant Investigative Site Mayfield Heights Ohio 44124 —
Dermavant Investigative Site Tulsa Oklahoma 74114 —
Dermavant Investigative Site Medford Oregon 97504 —
Dermavant Investigative Site Portland Oregon 97210 —
Dermavant Investigative Site Portland Oregon 97239 —
Dermavant Investigative Site East Greenwich Rhode Island 02818 —
Dermavant Investigative Site Anderson South Carolina 29621 —
Dermavant Investigative Site North Charleston South Carolina 29420 —
Dermavant Investigative Site Spartanburg South Carolina 29303 —
Dermavant Investigative Site Memphis Tennessee 38119 —
Dermavant Investigative Site Bellaire Texas 77401 —
Dermavant Investigative Site Dripping Springs Texas 78620 —
Dermavant Investigative Site Grapevine Texas 76051 —
Dermavant Investigative Site Houston Texas 77004 —
Dermavant Investigative Site Houston Texas 77061 —
Dermavant Investigative Site San Antonio Texas 78213 —
Dermavant Investigative Site Webster Texas 77598 —
Dermavant Investigative Site Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05032859, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 2, 2025 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05032859 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →